ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in December 2024. Updated December 23.
A roundup of FDA’s actions in December 2024.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in December 2024. Updated December 23.
A roundup of FDA’s actions in December 2024.